Skip to main content
David Adams, MD, Neurology, Miami, FL

DavidJ.AdamsMD

Neurology Miami, FL

Clinical Professor of Neurology, University Miami School of Medicine

Dr. Adams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Adams' full profile

Already have an account?

  • Office

    1150 NW 14th St
    Miami, FL 33136
    Phone+1 305-243-3100
    Fax+1 305-243-4678

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1970 - 1974
  • University of Washington School of Medicine
    University of Washington School of MedicineInternship, Transitional Year, 1969 - 1970
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1969

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2008 - 2024
  • NY State Medical License
    NY State Medical License 1970 - 2009
  • NJ State Medical License
    NJ State Medical License 1978 - 2007
  • GA State Medical License
    GA State Medical License 1992 - 1995
  • NC State Medical License
    NC State Medical License 1972 - 1982
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy: French Experience About Four Patients, Under the Behalf of French Society for Bone Marrow Transplantation
    Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy: French Experience About Four Patients, Under the Behalf of French Society for Bone Marrow TransplantationMarch 2nd, 2021
  • Oligonucleotide Drugs Show Promise in Transthyretin Amyloidosis
    Oligonucleotide Drugs Show Promise in Transthyretin AmyloidosisJuly 5th, 2018
  • Alnylam RNAi Drug Reverses Progress of Rare Fatal Disease: Study
    Alnylam RNAi Drug Reverses Progress of Rare Fatal Disease: StudyNovember 2nd, 2017
  • Join now to see all